Latest & greatest articles for HIV Test

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on HIV Test or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on HIV Test and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for HIV Test

121. HIV testing: increasing uptake in black Africans

HIV testing: increasing uptake in black Africans HIV testing: increasing uptake in black Africans | Guidance | NICE HIV testing: increasing uptake in black Africans Public health guideline [PH33] Published date: March 2011 Guidance This guidance has been updated and replaced by . Explore © NICE [year]. All rights reserved. Subject to .

2011 National Institute for Health and Clinical Excellence - Clinical Guidelines

122. The cost-effectiveness of HIV voluntary counseling and testing in China

The cost-effectiveness of HIV voluntary counseling and testing in China The cost-effectiveness of HIV voluntary counseling and testing in China The cost-effectiveness of HIV voluntary counseling and testing in China Wang S, Moss JR, Hiller JE Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment (...) on the reliability of the study and the conclusions drawn. CRD summary The study assessed the cost-effectiveness of free HIV voluntary counselling and testing in the general population and among men who have sex with men. The authors concluded that the HIV voluntary counselling and testing programme provided value-for-money in a high-risk population (such as men who have sex with men), but it was not cost-effective in the general population. The study used a conventional cost-effectiveness framework. The authors

2011 NHS Economic Evaluation Database.

123. HIV screening via fourth-generation immunoassay or nucleic acid amplification test in the United States: a cost-effectiveness analysis Full Text available with Trip Pro

HIV screening via fourth-generation immunoassay or nucleic acid amplification test in the United States: a cost-effectiveness analysis HIV screening via fourth-generation immunoassay or nucleic acid amplification test in the United States: a cost-effectiveness analysis HIV screening via fourth-generation immunoassay or nucleic acid amplification test in the United States: a cost-effectiveness analysis Long EF Record Status This is a critical abstract of an economic evaluation that meets (...) the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary The study assessed the population-based cost-effectiveness of universal or targeted HIV screening with a fourth-generation immunoassay versus screening for acute infection with a pooled nucleic acid amplification test for various screening frequencies and target populations

2011 NHS Economic Evaluation Database.

124. Promoting the uptake of HIV testing among men who have sex with men: systematic review of effectiveness and cost-effectiveness

Promoting the uptake of HIV testing among men who have sex with men: systematic review of effectiveness and cost-effectiveness Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2011 DARE.

125. The cost-effectiveness of symptom-based testing and routine screening for acute HIV infection in men who have sex with men in the USA Full Text available with Trip Pro

The cost-effectiveness of symptom-based testing and routine screening for acute HIV infection in men who have sex with men in the USA The cost-effectiveness of symptom-based testing and routine screening for acute HIV infection in men who have sex with men in the USA The cost-effectiveness of symptom-based testing and routine screening for acute HIV infection in men who have sex with men in the USA Juusola JL, Brandeau ML, Long EF, Owens DK, Bendavid E Record Status This is a critical abstract (...) was effective over 20 years, but the addition of symptom-based viral load testing was more effective and relatively inexpensive. The methods, analyses, and results were mostly clear, and the authors’ conclusions appear to be reasonable. Type of economic evaluation Cost-effectiveness analysis, cost-utility analysis Study objective The aim was to examine the cost-effectiveness of strategies to detect and treat HIV in men who have sex with men. The target population was men aged 13 to 64 years, which

2011 NHS Economic Evaluation Database.

126. Home-based HIV voluntary counselling and testing (VCT) for improving uptake of HIV testing. Full Text available with Trip Pro

Home-based HIV voluntary counselling and testing (VCT) for improving uptake of HIV testing. The low uptake of HIV voluntary counselling and testing (VCT) has hindered global attempts to prevent new HIV infections and has limited scale-up of HIV care and treatment. Globally, only 10% of HIV-infected individuals are aware of their HIV status. One approach to increase uptake is home-based HIV VCT, which may be effective in increasing the number of patients on treatment and preventing new (...) infections.To establish the effect of home-based HIV VCT on uptake of HIV testingWe searched MEDLINE (February 2007), EMBASE (February 2007), CENTRAL (February 2007), AIDSearch (February 2007), LILACS, CINAHL and Sociofile. We also contacted relevant researchers. The original review search strategy was updated in 2008.Randomised controlled trials comparing home-based HIV VCT with other testing modelsTwo review authors independently selected studies, assessed methodological quality, and extracted data. We

2010 Cochrane

127. Evaluation of an HIV nucleic acid testing program with automated Internet and voicemail systems to deliver results. Full Text available with Trip Pro

Evaluation of an HIV nucleic acid testing program with automated Internet and voicemail systems to deliver results. Nucleic acid testing (NAT) in routine HIV testing programs can increase the detection of infected individuals, but the most effective implementation of NAT remains unclear.To determine how many HIV cases can be identified with NAT and how many persons can be contacted, to identify predictors of acute and early HIV infection cases, and to test reporting of negative results (...) by automated Internet and voicemail systems.Prospective study.San Diego County, California.Persons seeking HIV testing.Rates and predictors of HIV infection by stage, notification of positive NAT results, use of automated Internet or voicemail systems to access negative NAT results, and estimated HIV infections prevented.Of 3151 persons tested, 79 had newly diagnosed cases of HIV: 64 had positive results from rapid HIV test, and 15 had positive results only by NAT (that is, NAT increased the HIV detection

2010 Annals of Internal Medicine

128. WITHDRAWN: Home-based HIV voluntary counseling and testing in developing countries. (Abstract)

WITHDRAWN: Home-based HIV voluntary counseling and testing in developing countries. The low uptake of HIV voluntary counseling and testing (VCT), an effective HIV prevention intervention, has hindered global attempts to prevent new HIV infections, as well as limiting the scale-up of HIV care and treatment for the estimated 38 million infected persons. According to UNAIDS, only 10% of HIV-infected individuals worldwide are aware of their HIV status. At this point in the HIV epidemic, a renewed (...) focus has shifted to prevention, and with it, a focus on methods to increase the uptake of HIV VCT. This review discusses home-based HIV VCT delivery models, which, given the low uptake of facility-based testing models, may be an effective avenue to get more patients on treatment and prevent new infections.(1) To identify and critically appraise studies addressing the implementation of home-based HIV voluntary counseling and testing in developing countries. (2) To determine whether home-based HIV

2010 Cochrane

129. Poor sensitivity of field rapid HIV testing: implications for mother-to-child transmission programme Full Text available with Trip Pro

Poor sensitivity of field rapid HIV testing: implications for mother-to-child transmission programme We validated rapid HIV tests among pregnant women in a clinical setting. Field testing was performed using First Response 1,2,3 or Standard Diagnostic and Pareekshak tests. Results were confirmed by third generation HIV ELISA. Discordant or negative, specimens were confirmed by RNA PCR and a fourth generation ELISA test. Sensitivity and specificity were 94.5% (CI: 85.8-98.2) and 100% for First

2010 EvidenceUpdates

130. The association of HIV susceptibility testing with survival among HIV-infected patients receiving antiretroviral therapy: a cohort study. (Abstract)

The association of HIV susceptibility testing with survival among HIV-infected patients receiving antiretroviral therapy: a cohort study. HIV-1 genotypic and phenotypic susceptibility testing (GPT) optimizes antiretroviral selection, but its effect on survival is unknown.To evaluate the association between GPT and survival.Cohort study.10 U.S. HIV clinics.2699 HIV-infected patients eligible for GPT (plasma HIV RNA level >1000 copies/mL) seen from 1999 through 2005.Demographic characteristics (...) , clinical factors, GPT use, all-cause mortality, and crude and adjusted hazard ratios (HRs) for the association of GPT with survival.Patients were followed for a median of 3.3 years; 915 (34%) had GPT. Patients who had GPT had lower mortality rates than those who did not (2.0 vs. 2.7 deaths per 100 person-years). In standard Cox models, GPT was associated with improved survival (adjusted HR, 0.69 [95% CI, 0.51 to 0.94]; P = 0.017) after controlling for demographic characteristics, CD4+ cell count, HIV

2009 Annals of Internal Medicine

131. Consistency of State Statutes With the Centers for Disease Control and Prevention HIV Testing Recommendations for Health Care Settings. Full Text available with Trip Pro

Consistency of State Statutes With the Centers for Disease Control and Prevention HIV Testing Recommendations for Health Care Settings. In September 2006, the Centers for Disease Control and Prevention (CDC) released the "Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-care Settings" to improve screening and diagnosis. The CDC now recommends that all patients in all health care settings be offered opt-out HIV screening without separate written (...) consent and prevention counseling. State law on HIV testing is widely assumed to be a barrier to implementing the recommendations. To help policymakers and providers better understand their own legal context and to correct possible misunderstandings about statutory compatibility, a state-by-state review (including Washington, DC) of all statutes pertaining to HIV testing was performed and the consistency of these laws with the new recommendations was systematically assessed. Criteria were developed

2009 Annals of Internal Medicine

132. Guidance for the HIV testing of children with HIV-positive parents

Guidance for the HIV testing of children with HIV-positive parents ‘Don’t Forget the Children’ MISSION STATEMENT The HIV status of all the children of known HIV-positive adults in the UK should be known as a matter of clinical urgency Guidance for the HIV testing of children with HIV-positive parents A consensus document produced jointly by BHIVA, CHIVA and BASHH‘Don’t Forget the Children’ Mediscript Ltd Guidance for the HIV testing of children with HIV-positive parentsBritish HIV Association (...) Guidance for the HIV testing of children with HIV-positive parents4 ‘Don’t Forget the Children’ The current situation ¦ Undiagnosed HIV is a well-recognised problem in the UK among adults and is associated with late presentation and increased morbidity and mortality. It is less well understood in children. ¦ The children of HIV-positive adults attending HIV services are a readily accessible group of children at risk of HIV infection. ¦ There is a current lack of robust protocols in place to ensure

2009 The Children's HIV Association

133. Improving HIV rapid testing rates among STD clinic patients: a randomized controlled trial Full Text available with Trip Pro

Improving HIV rapid testing rates among STD clinic patients: a randomized controlled trial The Centers for Disease Control and Prevention recommends that HIV testing be a standard part of medical care; however, testing is voluntary and some patients decline. We evaluated 2 brief interventions to promote rapid HIV testing among STD clinic patients who initially declined testing.Using a randomized controlled trial, patients either viewed an educational digital video disc (DVD) or participated (...) in stage-based behavioral counseling (SBC) provided by a nurse. Sixty clients presenting for care at a STD clinic who initially declined HIV testing at registration and during risk behavior screening participated in the study.The primary outcome was whether patients agreed to be tested for HIV. The secondary outcomes included attitudes, knowledge, and stage-of-change regarding HIV testing. Patients receiving both interventions improved their attitudes and knowledge about testing (ps < .01). Patients

2009 EvidenceUpdates Controlled trial quality: uncertain

134. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model

Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG Record Status (...) This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary The objective was to assess the costs and effectiveness of a strategy of universal voluntary human immunodeficiency virus (HIV) testing with immediate antiretroviral therapy, in the context of a heterosexual epidemic

2009 NHS Economic Evaluation Database.

135. The potential of provider-initiated voluntary HIV counseling and testing at health care settings in Thailand

The potential of provider-initiated voluntary HIV counseling and testing at health care settings in Thailand The potential of provider-initiated voluntary HIV counseling and testing at health care settings in Thailand The potential of provider-initiated voluntary HIV counseling and testing at health care settings in Thailand Teerawattananon Y, Leelukhanaveera Y, Hanvoravongchai P, Thavorncharoensap M, Ingsrisawang L, Tantivess S, Chaikledkaew U, Hiransuthikul N, Leartpiriyasuwat C Record Status (...) This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Teerawattananon Y, Leelukhanaveera Y, Hanvoravongchai P, Thavorncharoensap M, Ingsrisawang L, Tantivess S, Chaikledkaew U, Hiransuthikul N, Leartpiriyasuwat C. The potential of provider-initiated voluntary HIV counseling and testing at health care settings in Thailand. Thailand: Health Intervention and Technology Assessment

2009 Health Technology Assessment (HTA) Database.

136. HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis. Full Text available with Trip Pro

HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis. In the Step Study, the MRKAd5 HIV-1 gag/pol/nef vaccine did not reduce plasma viraemia after infection, and HIV-1 incidence was higher in vaccine-treated than in placebo-treated men with pre-existing adenovirus serotype 5 (Ad5) immunity. We assessed vaccine-induced immunity and its potential contributions to infection risk.To assess immunogenicity, we characterised HIV-specific T cells ex vivo (...) with validated interferon-gamma ELISPOT and intracellular cytokine staining assays, using a case-cohort design. To establish effects of vaccine and pre-existing Ad5 immunity on infection risk, we undertook flow cytometric studies to measure Ad5-specific T cells and circulating activated (Ki-67+/BcL-2(lo)) CD4+ T cells expressing CCR5.We detected interferon-gamma-secreting HIV-specific T cells (range 163/10(6) to 686/10(6) peripheral blood mononuclear cells) ex vivo by ELISPOT in 77% (258/354) of people

2008 Lancet

137. UK National Guidelines for HIV Testing

UK National Guidelines for HIV Testing 404 - Oops, can't find that 404 THE PAGE WAS NOT FOUND

2008 British Association for Sexual Health and HIV

138. Cost-effectiveness estimates for antenatal HIV testing in the Netherlands

Cost-effectiveness estimates for antenatal HIV testing in the Netherlands Cost-effectiveness estimates for antenatal HIV testing in the Netherlands Cost-effectiveness estimates for antenatal HIV testing in the Netherlands Rozenbaum MH, Verweel G, Folkerts DK, Dronkers F, van den Hoek JA, Hartwig NG, de Groot R, Postma MJ Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods (...) the costs of HIV screening, counselling, HAART drugs, diagnostic tests, delivery, formula feeding, and lifetime health care for infants infected with HIV. The order costs for tests, pharmacist fees for prescriptions, and both medical specialists’ and anaesthesiologists’ fees were included when required. The resource use data were based on published evidence and local patterns of care. Most of the costs were derived from official national prices and previous studies. The costs and quantities for lifetime

2008 NHS Economic Evaluation Database.

139. Perinatal HIV transmission and the cost-effectiveness of screening at 14 weeks gestation, at the onset of labour and the rapid testing of infants Full Text available with Trip Pro

Perinatal HIV transmission and the cost-effectiveness of screening at 14 weeks gestation, at the onset of labour and the rapid testing of infants Perinatal HIV transmission and the cost-effectiveness of screening at 14 weeks gestation, at the onset of labour and the rapid testing of infants Perinatal HIV transmission and the cost-effectiveness of screening at 14 weeks gestation, at the onset of labour and the rapid testing of infants Udeh B, Udeh C, Graves N Record Status This is a critical (...) , compared with the usual screening, resulted in cost savings of $737.30 and a gain of 0.2037 life-years per pregnant woman. All other strategies were dominated by this combination as they were more costly and less effective. The sensitivity analyses demonstrated that the results were robust. The dominance of the combination strategy was remained with all variations tested, except when the life expectancy of an HIV-positive mother with a normal diagnosis or the HIV transmission rate were varied

2008 NHS Economic Evaluation Database.

140. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Full Text available with Trip Pro

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Observational data and non-human primate challenge studies suggest that cell-mediated immune responses might provide control of HIV replication. The Step Study directly assessed the efficacy of a cell-mediated immunity vaccine to protect against HIV-1 infection or change in early plasma HIV-1 levels.We undertook a double-blind, phase II, test (...) -of-concept study at 34 sites in North America, the Caribbean, South America, and Australia. We randomly assigned 3000 HIV-1-seronegative participants by computer-generated assignments to receive three injections of MRKAd5 HIV-1 gag/pol/nef vaccine (n=1494) or placebo (n=1506). Randomisation was prestratified by sex, adenovirus type 5 (Ad5) antibody titre at baseline, and study site. Primary objective was a reduction in HIV-1 acquisition rates (tested every 6 months) or a decrease in HIV-1 viral-load

2008 Lancet Controlled trial quality: predicted high